Profectus BioSciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Profectus BioSciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10841
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Profectus BioSciences Inc (Profectus) is a clinical-stage vaccine development company that designs and develops preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy. The company’s products include genevax therapeutic vaccines, vesiculovax prophylactic vaccines and additional prophylactic vaccines. It uses PBS Vax technology platform for the development of new vaccines. Profectus’ products are used in the treatment of major chronic infectious diseases of public health and biodefense. The company also develops vaccines for pre- and post-exposure protection against the hemorrhagic disease caused by ebola and marburg viruses. It also develops oncolytic vaccines for cancer immunotherapy. The company partners with research laboratories and universities. Profectus is headquartered in Baltimore, Maryland, the US.

Profectus BioSciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Profectus BioSciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Profectus BioSciences Raises USD0.3 Million in Venture Financing 10
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 11
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 12
Profectus BioSciences Raises US$0.8 Million In Extended Series C Financing 13
Partnerships 14
CEPI Enters into Partnership with Profectus BioSciences and Emergent BioSolutions 14
CEPI Enters into Collaboration with Profectus BioSciences and Emergent BioSolutions 15
Profectus BioSciences Forms Joint Venture with Medisun Holdings 16
Profectus BioSciences Enters into Co-Development Agreement with Vyriad 17
Licensing Agreements 18
Profectus BioSciences Enters into Licensing Agreement with Henry M. Jackson 18
Profectus BioSciences Inc – Key Competitors 19
Profectus BioSciences Inc – Key Employees 20
Profectus BioSciences Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Recent Developments 22
Clinical Trials 22
Jan 09, 2017: Profectus BioSciences Bivalent Vaccine Protects Animals from Infection and Death After Exposure to Chikungunya or Zika Virus 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Profectus BioSciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Profectus BioSciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Profectus BioSciences Raises USD0.3 Million in Venture Financing 10
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 11
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 12
Profectus BioSciences Raises US$0.8 Million In Extended Series C Financing 13
CEPI Enters into Partnership with Profectus BioSciences and Emergent BioSolutions 14
CEPI Enters into Collaboration with Profectus BioSciences and Emergent BioSolutions 15
Profectus BioSciences Forms Joint Venture with Medisun Holdings 16
Profectus BioSciences Enters into Co-Development Agreement with Vyriad 17
Profectus BioSciences Enters into Licensing Agreement with Henry M. Jackson 18
Profectus BioSciences Inc, Key Competitors 19
Profectus BioSciences Inc, Key Employees 20
Profectus BioSciences Inc, Other Locations 21
Profectus BioSciences Inc, Joint Venture 21

List of Figures
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Profectus BioSciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Microchip Technology Incorporated:企業の戦略・SWOT・財務分析
    Microchip Technology Incorporated - Strategy, SWOT and Corporate Finance Report Summary Microchip Technology Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • New York Life Insurance Company:企業のM&A・事業提携・投資動向
    New York Life Insurance Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New York Life Insurance Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Imobiliaria Construtora Grao-Para SA:企業の戦略・SWOT・財務情報
    Imobiliaria Construtora Grao-Para SA - Strategy, SWOT and Corporate Finance Report Summary Imobiliaria Construtora Grao-Para SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • First Solar, Inc.:企業のM&A・事業提携・投資動向
    First Solar, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Solar, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Nippon Yusen Kabushiki Kaisha (9101):石油・ガス:M&Aディール及び事業提携情報
    Summary Nippon Yusen Kabushiki Kaisha (NYK) is a logistics company. It transports crude oil and allied products. The company provides ocean, land, and air transport services for the transportation of petroleum products, liquid products and dry bulk products. Its portfolio includes linear trade, air …
  • Amazon.com Inc (AMZN):企業の財務・戦略的SWOT分析
    Amazon.com Inc (AMZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pioneer Natural Resources Company:企業の戦略・SWOT・財務情報
    Pioneer Natural Resources Company - Strategy, SWOT and Corporate Finance Report Summary Pioneer Natural Resources Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Lensar Inc-医療機器分野:企業M&A・提携分析
    Summary Lensar Inc (Lensar), a subsidiary of Alphaeon Corp is a medical device company that designs, develops and manufactures laser and advanced 3D imaging technology and devices for refractive cataract surgery. The company provides surgeon with superior femtosecond laser technology. It offers vari …
  • Rizal Commercial Banking Corp (RCB):電力:M&Aディール及び事業提携情報
    Summary Rizal Commercial Banking Corp (RCBC) is a commercial and financial banking service provider that offers corporate, commercial, and consumer banking, cash management, treasury, and remittance products and services. The company’s electronic banking services include mobile banking, internet ban …
  • Spinal Kinetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Spinal Kinetics Inc (SKG) is a medical device company that develops motion preservation systems for treating degenerative diseases of the spine. The company provides products such as M6-C artificial cervical disc and M6-L artificial lumbar disc. The M6 artificial cervical disc offers an opti …
  • CMS Energy Corporation (CMS):電力:M&Aディール及び事業提携情報
    Summary CMS Energy Corporation (CMS Energy) is an energy utility which provides electricity, natural gas, and banking services. It generates, procures, transmits, distributes, and sells energy. The company produces power from coal, oil and gas, hydro, wind, and solar sources. CMS Energy purchases, t …
  • Randstad Holding nv:企業の戦略・SWOT・財務情報
    Randstad Holding nv - Strategy, SWOT and Corporate Finance Report Summary Randstad Holding nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Zimplats Holdings Ltd:企業の戦略・SWOT・財務分析
    Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kforce Inc (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • American Woodmark Corp (AMWD):企業の財務・戦略的SWOT分析
    American Woodmark Corp (AMWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Polish Oil and Gas Company (PGNiG SA):戦略・SWOT・企業財務分析
    Polish Oil and Gas Company (PGNiG SA) - Strategy, SWOT and Corporate Finance Report Summary Polish Oil and Gas Company (PGNiG SA) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Acer Incorporated:企業の戦略・SWOT・財務情報
    Acer Incorporated - Strategy, SWOT and Corporate Finance Report Summary Acer Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • NuVista Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    NuVista Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary NuVista Energy Ltd (NuVista) is an oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company conducts its operations in Western Canadian …
  • PharmaCyte Biotech Inc (PMCB)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company’s technology is used for the treatment of advanced and inoperable pancreatic cancer, and diabetes. It develops …
  • Humanigen Inc (HGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Humanigen Inc (Humanigen), formerly KaloBios Pharmaceuticals Inc is a biopharmaceutical company that develops proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company provides Ifabotuzumab(anti-EphA3) and Lenzilumab(anti-GM-CSF) recombinant monoclonal antibodi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆